These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9178144)

  • 1. Investigation of the influenza-like symptoms associated with recombinant human erythropoietin therapy.
    Takemasa A; Yorioka N; Yamakido M
    J Int Med Res; 1997; 25(3):127-34. PubMed ID: 9178144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human erythropoietin increases interleukin-1 beta production in cultured peripheral blood mononuclear cells from patients resistant to recombinant human erythropoietin therapy.
    Takemasa A; Yorioka N; Ito T; Yamashita K; Oda H; Yamakido M
    Nephron; 1994; 67(2):245-7. PubMed ID: 8072621
    [No Abstract]   [Full Text] [Related]  

  • 3. Stimulation of interleukin-1 beta production may be involved in unresponsiveness to erythropoietin therapy.
    Takemasa A; Yorioka N; Yamakido M
    Int J Artif Organs; 1996 Nov; 19(11):633-7. PubMed ID: 8970830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF; Law CB; Ting SM; Li P; Lai KN
    Clin Nephrol; 1991 Nov; 36(5):246-51. PubMed ID: 1752075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of erythropoietin in continuous ambulatory peritoneal dialysis patients: comparison between intravenous and intraperitoneal administration.
    Nasu T; Mitui H; Shinohara Y; Hayashida S; Ohtuka H
    Perit Dial Int; 1992; 12(4):373-7. PubMed ID: 1420496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized prospective comparison between erythropoietin and androgens in CAPD patients.
    Navarro JF; Mora C; Macía M; García J
    Kidney Int; 2002 Apr; 61(4):1537-44. PubMed ID: 11918762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of tumour necrosis factor-alpha production by recombinant human erythropoietin may contribute to failure of therapy.
    Takemasa A; Yorioka N; Ueda C; Amimoto D; Taniguchi Y; Yamakido M
    Scand J Urol Nephrol; 2000 Apr; 34(2):131-5. PubMed ID: 10903076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of proinflammatory cytokine gene and angiotensin-converting enzyme polymorphisms on erythropoietin requirements in patients on continuous ambulatory peritoneal dialysis.
    Sharples EJ; Varagunam M; Sinnott PJ; McCloskey DJ; Raftery MJ; Yaqoob MM
    Perit Dial Int; 2006; 26(1):64-8. PubMed ID: 16538877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of erythropoietin with oral iron in peritoneal dialysis and hemodialysis patients.
    Raja R; Bloom E; Johnson R
    Adv Perit Dial; 1993; 9():177-80. PubMed ID: 8105918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of association between interleukin-17 and interferon-gamma and recombinant human erythropoietin dose in patients undergoing peritoneal dialysis.
    de Oliveira WV; de Figueiredo RC; de Paula AS; Turani SD; Velloso MSS; Pinheiro MB; Gomes KB; Marinho MAS; Pinto SWL; Rios DRA
    Cytokine; 2017 Aug; 96():24-29. PubMed ID: 28282547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF; Chung WW; Leung CB; Chan K; Lai KN
    Clin Nephrol; 1990 Jan; 33(1):47-51. PubMed ID: 2302870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose escalation induces tolerance to side-effects of erythropoietin in a patient with dialysis anaemia: case report.
    Ohira N; Takasugi K; Takasugi N; Yorioka N; Ito T; Kushihata S; Takemasa A
    J Int Med Res; 1998; 26(2):102-5. PubMed ID: 9602990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anemia of chronic renal failure: treatment with erythropoietin.
    Navarro M; Alonso A; Avilla JM; Espinosa L
    Child Nephrol Urol; 1991; 11(3):146-51. PubMed ID: 1777893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin for anaemia in haemodialysis patients: results of a maintenance study (the Canadian Erythropoietin Study Group).
    Muirhead N; Laupacis A; Wong C
    Nephrol Dial Transplant; 1992; 7(8):811-6. PubMed ID: 1325613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction of anemia in patients on continuous ambulatory peritoneal dialysis with subcutaneous recombinant erythropoietin twice a week: a long-term study.
    Cheng IK; Cy C; Chan MK; Yu L; Fang GX; Wei D
    Clin Nephrol; 1991 May; 35(5):207-12. PubMed ID: 1855328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin with oral iron in peritoneal and hemodialysis patients. A comparison in an inner city population.
    Raja R; Bloom E; Goldstein M; Johnson R
    ASAIO J; 1993; 39(3):M578-80. PubMed ID: 8268603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human erythropoietin in a patient with multiple myeloma and end-stage renal disease.
    Holley JL; Nolan TA; Piraino B
    Clin Nephrol; 1992 Mar; 37(3):145-7. PubMed ID: 1563119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain after subcutaneous injection of recombinant human erythropoietin: does Emla cream help?
    Morris KP; Hughes C; Hardy SP; Matthews JN; Coulthard MG
    Nephrol Dial Transplant; 1994; 9(9):1299-301. PubMed ID: 7816294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-year experience of very low doses of subcutaneous erythropoietin in continuous ambulatory peritoneal dialysis and its effect on haemostasis.
    Huraib S; Gader AM; al-Momen AK; Abu-Aisha H; al-Wakeel J; Memon NA
    Haemostasis; 1995; 25(6):299-304. PubMed ID: 8586321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients.
    Brunkhorst R; Bommer J; Braun J; Haag-Weber M; Gill C; Wagner J; Wagener T;
    Nephrol Dial Transplant; 2004 May; 19(5):1224-30. PubMed ID: 14993489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.